204 related articles for article (PubMed ID: 34198589)
1. Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging.
Kim DH; Choi SH; Shim JH; Kim SY; Lee SS; Byun JH; Choi JI
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198589
[TBL] [Abstract][Full Text] [Related]
2. Inter-reader agreement of abbreviated magnetic resonance imaging for hepatocellular carcinoma detection: a systematic review and meta-analysis.
Kim DH; Choi SH; Lee JS; Choi JI
Abdom Radiol (NY); 2022 Jan; 47(1):123-132. PubMed ID: 34633497
[TBL] [Abstract][Full Text] [Related]
3. Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment.
Jeon SK; Lee DH; Hur BY; Park SJ; Kim SW; Park J; Suh KS; Lee KW; Yi NJ; Han JK
J Magn Reson Imaging; 2023 Nov; 58(5):1375-1383. PubMed ID: 36825827
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
[TBL] [Abstract][Full Text] [Related]
5. Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.
Gupta P; Soundararajan R; Patel A; Kumar-M P; Sharma V; Kalra N
J Hepatol; 2021 Jul; 75(1):108-119. PubMed ID: 33548385
[TBL] [Abstract][Full Text] [Related]
6. Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies.
Lee JH; Kim YK; Min JH; Cha D; Hwang JA; Ahn S
Clin Imaging; 2023 Sep; 101():206-214. PubMed ID: 37421716
[TBL] [Abstract][Full Text] [Related]
7. Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.
Kim DH; Yoon JH; Choi MH; Lee CH; Kang TW; Kim HA; Ku YM; Lee JM; Kim SH; Kim KA; Lee SL; Choi JI
J Hepatol; 2024 Apr; ():. PubMed ID: 38636849
[TBL] [Abstract][Full Text] [Related]
8. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
Girardet R; Dubois M; Manasseh G; Jreige M; Du Pasquier C; Canniff E; Gulizia M; Bonvin M; Aleman Y; Taouli B; Fraga M; Dromain C; Vietti Violi N
Eur Radiol; 2023 Oct; 33(10):6929-6938. PubMed ID: 37464111
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
Besa C; Lewis S; Pandharipande PV; Chhatwal J; Kamath A; Cooper N; Knight-Greenfield A; Babb JS; Boffetta P; Padron N; Sirlin CB; Taouli B
Abdom Radiol (NY); 2017 Jan; 42(1):179-190. PubMed ID: 27448609
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Kim DH; Choi SH; Shim JH; Kim SY; Lee SS; Byun JH; Kim KW; Choi JI
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574006
[TBL] [Abstract][Full Text] [Related]
11. Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance.
Park HJ; Seo N; Kim SY
Korean J Radiol; 2022 Jun; 23(6):598-614. PubMed ID: 35434979
[TBL] [Abstract][Full Text] [Related]
12. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.
Khatri G; Pedrosa I; Ananthakrishnan L; de Leon AD; Fetzer DT; Leyendecker J; Singal AG; Xi Y; Yopp A; Yokoo T
J Magn Reson Imaging; 2020 Feb; 51(2):415-425. PubMed ID: 31209978
[TBL] [Abstract][Full Text] [Related]
13. Abbreviated Liver Magnetic Resonance Imaging Protocols and Applications.
Altinmakas E; Taouli B
Radiol Clin North Am; 2022 Sep; 60(5):695-703. PubMed ID: 35989038
[TBL] [Abstract][Full Text] [Related]
14. Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis.
Decharatanachart P; Pan-Ngum W; Peeraphatdit T; Tanpowpong N; Tangkijvanich P; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
Gut Liver; 2024 Jan; 18(1):135-146. PubMed ID: 37560799
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of Abbreviated MRI for HCC Detection in Patients with Non-alcoholic Fatty Liver Disease.
Soundararajan R; Pooja AB; Gupta P; Gulati A; Kalra N; Singh S; Premkumar M; Taneja S; Jearth V; Sharma V; Duseja A
J Clin Exp Hepatol; 2024; 14(1):101276. PubMed ID: 38076364
[TBL] [Abstract][Full Text] [Related]
16. Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI.
Brunsing RL; Fowler KJ; Yokoo T; Cunha GM; Sirlin CB; Marks RM
Hepatoma Res; 2020; 6():. PubMed ID: 33381651
[TBL] [Abstract][Full Text] [Related]
17. Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients.
Park HJ; Kim SY; Singal AG; Lee SJ; Won HJ; Byun JH; Choi SH; Yokoo T; Kim MJ; Lim YS
Liver Int; 2022 Aug; 42(9):2080-2092. PubMed ID: 34817921
[TBL] [Abstract][Full Text] [Related]
18. Abbreviated MRI for HCC surveillance: is it ready for clinical use?
Vietti Violi N; Taouli B
Eur Radiol; 2020 Aug; 30(8):4147-4149. PubMed ID: 32394280
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.
Huang DQ; Fowler KJ; Liau J; Cunha GM; Louie AL; An JY; Bettencourt R; Jung J; Gitto Z; Hernandez C; Lopez SJ; Gupta H; Sirlin CB; Marks RM; Loomba R
Aliment Pharmacol Ther; 2022 Apr; 55(7):820-827. PubMed ID: 35229334
[TBL] [Abstract][Full Text] [Related]
20. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
Canellas R; Patel MJ; Agarwal S; Sahani DV
Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
